호흡용 일회용 의료기기 시장 : 제품 유형, 소재, 용도, 최종사용자, 유통 채널별 - 세계 시장 예측(2026-2032년)

The Respiratory Disposable Device Market is projected to grow by USD 4.58 billion at a CAGR of 9.91% by 2032.

Respiratory Disposable Device Market Introduction

Respiratory disposable devices are essential single-use medical products that support oxygen delivery, aerosol therapy, ventilation, airway protection, filtration, and infection prevention across hospitals, ambulatory care, emergency response, long-term care, and home healthcare. The category includes oxygen masks, nasal cannulas, nebulizer kits, breathing circuits, bacterial and viral filters, resuscitators, spacers, tracheostomy accessories, humidification components, and disposable parts used with respiratory therapy equipment.

Demand is supported by durable clinical drivers. The World Health Organization identifies chronic obstructive pulmonary disease as the third leading cause of death globally, while asthma affected an estimated 262 million people in 2019. Aging populations, air pollution exposure, recurring respiratory infections, surgical volumes, neonatal and critical care needs, and the expansion of home-based care continue to increase reliance on safe, sterile, and cost-efficient disposable respiratory products.

Transformative Shifts in the Respiratory Disposable Device Landscape

The respiratory disposable device landscape is shifting from commodity procurement toward resilience, standardization, infection prevention, and patient-specific care. Hospitals are balancing infection-control requirements with cost containment, while health systems are building stronger stockpiles after COVID-19 revealed vulnerabilities in global supply chains for masks, filters, circuits, and oxygen-delivery accessories.

Regulatory expectations are also transforming the market. U.S. FDA quality system requirements, EU Medical Device Regulation obligations, Unique Device Identification, ISO-based risk management, biocompatibility testing, and sterilization validation are raising the bar for documentation and post-market surveillance. At the same time, sustainability pressure is encouraging manufacturers to reduce material waste, improve recyclable packaging, optimize logistics, and evaluate lower-carbon production without compromising sterility or clinical performance.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly influencing respiratory disposable devices through demand planning, manufacturing quality control, procurement optimization, and clinical workflow integration. AI-enabled analytics can help hospitals predict consumption of nasal cannulas, masks, filters, nebulizer kits, and breathing circuits based on admissions, seasonal respiratory infections, ICU utilization, emergency department demand, and surgical schedules, reducing both stockouts and excess inventory.

In manufacturing, machine vision and predictive maintenance can improve defect detection, lot traceability, and process stability for high-volume molded plastics and assembled components. In clinical settings, AI connected to ventilators, pulse oximetry, respiratory monitors, and electronic health records may indirectly increase the value of disposable accessories by supporting earlier intervention, appropriate therapy selection, and better utilization of respiratory care pathways.

Key Regional Insights

Asia-Pacific is a major demand center as China, India, Japan, South Korea, Australia, and ASEAN economies expand hospital capacity, insurance coverage, emergency preparedness, and domestic medical device manufacturing. Large patient populations, urban air pollution, aging demographics in developed Asian economies, and the rising burden of chronic respiratory disease support sustained demand for oxygen therapy, aerosol-delivery consumables, filters, and ventilation accessories.

North America remains a high-value region because of advanced critical care infrastructure, established reimbursement channels, home respiratory therapy adoption, and strict FDA and Health Canada oversight. Latin America is improving access through public hospital modernization, private healthcare expansion, and growing procurement of affordable respiratory consumables, particularly in Mexico and Brazil. Europe benefits from mature procurement systems, EU MDR-driven quality expectations, UDI traceability, and strong infection-prevention standards. The Middle East, led by GCC investment in tertiary care, emergency medicine, and medical tourism, shows demand for premium respiratory disposables, while Africa's opportunity is tied to essential oxygen access, infection control, maternal and child health services, and resilient low-cost supply models.

Key Group Insights

ASEAN demand is shaped by hospital expansion, medical tourism, urbanization, and stronger local distribution networks, particularly in Indonesia, Thailand, Vietnam, Malaysia, and the Philippines. The GCC is prioritizing advanced hospitals, emergency preparedness, specialized respiratory care, and imported premium devices, creating opportunities for suppliers with regulatory readiness, consistent quality documentation, and reliable logistics.

The European Union emphasizes MDR compliance, sustainability, UDI traceability, clinical evidence, and tender-based purchasing, making quality documentation a commercial requirement. BRICS countries combine large patient pools with domestic manufacturing ambitions, cost-sensitive procurement, and rising investment in public healthcare capacity. G7 markets prioritize innovation, high clinical standards, supply-chain security, and robust post-market surveillance. NATO members add a defense and emergency-readiness dimension, supporting procurement of respiratory consumables for disaster response, field medicine, pandemic preparedness, and strategic reserves.

Key Country Insights

The United States leads in high-acuity respiratory care, home oxygen therapy, emergency response, and FDA-regulated product adoption, while Canada emphasizes standardized quality, public procurement, infection prevention, and equitable access. Mexico and Brazil provide scale in Latin America, supported by expanding hospital networks, public health demand, and rising need for affordable respiratory consumables across acute care and outpatient settings.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are mature respiratory disposable device markets shaped by public tenders, infection prevention, aging populations, and EU or national regulatory controls, while Russia's demand is influenced by domestic sourcing, hospital infrastructure needs, and continuity of medical supply. China and India represent high-volume opportunities due to population scale, respiratory disease burden, air quality concerns, expanding hospital capacity, and manufacturing strength. Japan, Australia, and South Korea offer premium opportunities driven by aging demographics, advanced hospitals, strong quality expectations, digital health adoption, and established critical care capabilities.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize respiratory disposable device portfolios that combine clinical reliability, cost efficiency, usability, and regulatory readiness. High-demand categories such as oxygen masks, nasal cannulas, nebulizer kits, filters, breathing circuits, resuscitation accessories, and tracheostomy components should be supported by validated sterilization, biocompatibility documentation, UDI compliance, lot traceability, and robust supplier qualification.

Manufacturers should diversify production footprints, build regional inventory buffers, qualify alternate suppliers, and use AI-enabled forecasting to align output with respiratory infection cycles, ICU utilization, and hospital purchasing patterns. Commercial teams should tailor value propositions by market maturity: premium performance, traceability, and clinical support in regulated markets; affordability and availability in emerging markets; and sustainability credentials, waste reduction, and compliant documentation in tender-driven health systems.

Research Methodology

This executive summary is based on secondary research from verified public-health, regulatory, and industry sources, including WHO disease burden data, national healthcare agencies, medical device regulatory frameworks, standards bodies, public procurement trends, and documented healthcare infrastructure indicators. The analysis emphasizes validated directional insights and avoids unsupported market-size, market-share, or forecasting claims.

Research inputs were triangulated across clinical demand drivers, regional healthcare investment patterns, regulatory requirements, supply-chain dynamics, infection-prevention practices, home healthcare adoption, and technology trends. Qualitative assessment was applied to evaluate how respiratory disease prevalence, aging populations, air pollution, hospital capacity, emergency preparedness, and AI-enabled operations affect demand for respiratory disposable devices.

Conclusion

The respiratory disposable device market is positioned for sustained relevance as healthcare systems manage chronic respiratory disease, acute infections, aging populations, surgical care, emergency medicine, and the need for safe oxygen and ventilation support. Single-use masks, cannulas, circuits, filters, nebulizer kits, and therapy accessories remain critical to infection control, clinical efficiency, and care continuity across hospital and home settings.

Future competitiveness will depend on verified quality, resilient supply chains, regional compliance, sustainable design, and data-enabled operations. Manufacturers and suppliers that integrate regulatory discipline, clinical usability, AI-supported planning, responsible materials management, and market-specific pricing will be best positioned to meet demand across both mature and emerging healthcare systems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Respiratory Disposable Device Market, by Product Type

• 7.1. Respiratory Masks
  • 7.1.1. Surgical Masks
  • 7.1.2. Procedure Masks
  • 7.1.3. N95 Respirators
• 7.2. Oxygen Delivery Devices
  • 7.2.1. Nasal Cannula
  • 7.2.2. Oxygen Masks
  • 7.2.3. Oxygen Tubing
• 7.3. Ventilatory Support Disposables
  • 7.3.1. Ventilator Circuits
  • 7.3.2. Endotracheal Tubes
  • 7.3.3. Tracheostomy Tubes
• 7.4. Airway Management Devices
  • 7.4.1. Laryngeal Mask Airways
  • 7.4.2. Oropharyngeal Airways
  • 7.4.3. Nasopharyngeal Airways

8. Respiratory Disposable Device Market, by Material

• 8.1. Polyurethane
• 8.2. Polyethylene
• 8.3. Polyvinyl Chloride
• 8.4. Silicone
• 8.5. Thermoplastic Elastomers

9. Respiratory Disposable Device Market, by Application

• 9.1. Anesthesia
• 9.2. Intensive Care
  • 9.2.1. Acute Respiratory Failure Management
  • 9.2.2. Mechanical Ventilation Support
• 9.3. Emergency Care
  • 9.3.1. Cardiac Arrest Management
  • 9.3.2. Acute Hypoxia Management
• 9.4. Infectious Disease Management
  • 9.4.1. Airborne Infection Control
  • 9.4.2. Isolation Care
  • 9.4.3. Pandemic Response Care
• 9.5. Chronic Respiratory Disease Management
• 9.6. Surgical Procedures

10. Respiratory Disposable Device Market, by End User

• 10.1. Ambulatory Surgical Centers
• 10.2. Clinics
• 10.3. Home Healthcare Settings
• 10.4. Hospitals

11. Respiratory Disposable Device Market, by Distribution Channel

• 11.1. Online
  • 11.1.1. eCommerce Platforms
  • 11.1.2. Company Websites
• 11.2. Offline

12. Respiratory Disposable Device Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Respiratory Disposable Device Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Respiratory Disposable Device Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Concentration Analysis, 2025
  • 15.1.1. Concentration Ratio (CR)
  • 15.1.2. Herfindahl Hirschman Index (HHI)
• 15.2. Recent Developments & Impact Analysis, 2025
• 15.3. Product Portfolio Analysis, 2025
• 15.4. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. 3M Company
• 16.2. Allied Healthcare Products, Inc.
• 16.3. Ambu A/S
• 16.4. Besmed Health Business Corp.
• 16.5. Dragerwerk AG & Co. KGaA
• 16.6. Dynarex Corporation
• 16.7. Fisher & Paykel Healthcare Corporation Limited
• 16.8. Flexicare Medical Limited
• 16.9. GaleMed Corporation
• 16.10. GE HealthCare Technologies Inc.
• 16.11. Getinge AB
• 16.12. Great Group Medical Co., Ltd.
• 16.13. Hamilton Medical AG
• 16.14. Henso Medical (Hangzhou) Co., Ltd.
• 16.15. Intersurgical Ltd.
• 16.16. Koninklijke Philips N.V.
• 16.17. Medline Industries, LP
• 16.18. Medtronic plc
• 16.19. Mercury Medical
• 16.20. Mindray Medical International Limited
• 16.21. Nihon Kohden Corporation
• 16.22. Pulmodyne, Inc.
• 16.23. ResMed Inc.
• 16.24. Smiths Medical, Inc.
• 16.25. SunMed, LLC
• 16.26. Teleflex Incorporated
• 16.27. Venture Medical, LLC
• 16.28. Vyaire Medical, Inc.
• 16.29. Westmed, Inc.